World Journal of AIDS

Volume 2, Issue 2 (June 2012)

ISSN Print: 2160-8814   ISSN Online: 2160-8822

Google-based Impact Factor: 0.22  Citations  

Treatment 2.0 Pilot in Vietnam—Early Progress and Challenges

HTML  XML Download Download as PDF (Size: 213KB)  PP. 64-70  
DOI: 10.4236/wja.2012.22009    5,075 Downloads   8,478 Views  Citations

ABSTRACT

Announced in 2010 at the International AIDS Conference in Vienna and pioneered by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization's (WHO) leadership at the global level, Treatment 2.0 is a new approach to the HIV response that encourages innovation, efficiency, and sustainability. Building upon WHO and UNAIDS' "3 by 5" Initiative, Treatment 2.0 focuses upon scale-up and universal access of life-saving ART treatment through strategic investments and innovations in five priority pillars that include: 1) Optimize drug regimens, 2) Provide point-of-care (POC) and other simplified diagnostic and monitoring tools, 3) Reduce costs, 4) Adapt service delivery, and 5) Mobilize communities [1-3]. The Treatment 2.0 approach is in line with UNAIDS' 2011-2015 Strategy: Getting to Zero with the vision of, "Zero New infections; Zero discrimination; and Zero AIDS-related deaths", and as well as the four strategic directions for the health sector response outlined under WHO's Global Health Sector Strategy on HIV/AIDS 2011-2015 [4,5]. At the Sixty-fourth World Health Assembly (WHA) in May 2011, it was formally announced that Vietnam has taken the leadership to pilot Treatment 2.0 in two of its provinces, with support from both the WHO and UNAIDS country offices [6,7]. Given that Vietnam is one of the few countries with a concentrated epidemic to pilot Treatment 2.0, the outcomes and experiences of this initiative can provide valuable insight to other countries who may consider implementation. The objectives of this article are therefore to: 1) Describe the early process for translating Treatment 2.0 concept in Vietnam's context; and 2) Highlight early progress and challenges.

Share and Cite:

D. Duong Bui, F. Mesquita, T. Nhan Do, M. Kato, T. Van Nguyen, T. Thu Nguyen and A. Poon, "Treatment 2.0 Pilot in Vietnam—Early Progress and Challenges," World Journal of AIDS, Vol. 2 No. 2, 2012, pp. 64-70. doi: 10.4236/wja.2012.22009.

Cited by

[1] Networking community health workers for service integration: role of social media
AIDS care, 2022
[2] How to be self-reliant in the context of stigma? The dilemma of people who inject drugs in Vietnam
Journal of Ethnicity in …, 2022
[3] A sociological study to explore the knowledge of Pre-Exposure Prophylaxis at Rhodes University.
2019
[4] The public health responses to HIV/AIDS in Vietnam.
2016
[5] HIV and Injecting Drug Users in Vietnam: An Overview of Policies and Responses
World Medical & Health Policy, 2014
[6] Caught in the Middle: The Contested Politics of HIV/AIDS and Health Policy in Vietnam
Journal of health politics, policy and law, 2014
[7] Enhancing the Benefits of Antiretroviral Therapy in Vietnam: Towards Ending AIDS
Current HIV/AIDS Reports, 2014
[8] Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region
Sexual health, 2014
[9] The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
[10] Treatment 2.0: catalyzing the next phase of treatment, care and support
Current Opinion in HIV and AIDS, 2013
[11] The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV trans
Journal of acquired immune deficiency syndromes, 2013
[12] AN OUTCOME BASED NUTRITION CURRICULUM FOR COUNSELORS AT HIV VOLUNTARY COUNSELING AND TESTING FACILITIES IN VIETNAM
Southeast Asian Journal of Tropical Medicine and Public Health, 2013
[13] THE PUBLIC HEALTH RESPONSES TO HIV/AIDS IN VIETNAM
European International Journal of Science and Technology , 2013

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.